Imamura Takahisa, Tanase Sumio, Szmyd Grzegorz, Kozik Andrzej, Travis James, Potempa Jan
Division of Molecular Pathology, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto 860-8556, Japan.
J Exp Med. 2005 May 16;201(10):1669-76. doi: 10.1084/jem.20042041.
Staphylococcus aureus is a major pathogen of gram-positive septic shock and frequently is associated with consumption of plasma kininogen. We examined the vascular leakage (VL) activity of two cysteine proteinases that are secreted by S. aureus. Proteolytically active staphopain A (ScpA) induced VL in a bradykinin (BK) B(2)-receptor-dependent manner in guinea pig skin. This effect was augmented by staphopain B (SspB), which, by itself, had no VL activity. ScpA also produced VL activity from human plasma, apparently by acting directly on kininogens to release BK, which again was augmented significantly by SspB. Intravenous injection of ScpA into a guinea pig caused BK B(2)-receptor-dependent hypotension. ScpA and SspB together induced the release of leucyl-methionyl-lysyl-BK, a novel kinin with VL and blood pressure-lowering activities that are equivalent to BK. Collectively, these data suggest that production of BK and leucyl-methionyl-lysyl-BK by staphopains is a new mechanism of S. aureus virulence and bacterial shock. Therefore, staphopain-specific inhibitors and kinin-receptor antagonists could be used to treat this disease.
金黄色葡萄球菌是革兰氏阳性败血症休克的主要病原体,且常常与血浆激肽原的消耗有关。我们检测了金黄色葡萄球菌分泌的两种半胱氨酸蛋白酶的血管渗漏(VL)活性。具有蛋白水解活性的葡萄球菌蛋白酶A(ScpA)在豚鼠皮肤中以缓激肽(BK)B₂受体依赖的方式诱导血管渗漏。葡萄球菌蛋白酶B(SspB)增强了这种效应,而其本身并无血管渗漏活性。ScpA显然通过直接作用于激肽原以释放BK,也从人血浆中产生血管渗漏活性,这种效应同样被SspB显著增强。向豚鼠静脉注射ScpA会引起BK B₂受体依赖的低血压。ScpA和SspB共同诱导了亮氨酰-甲硫氨酰-赖氨酰-BK的释放,这是一种具有与BK相当的血管渗漏和降压活性的新型激肽。总体而言,这些数据表明葡萄球菌蛋白酶产生BK和亮氨酰-甲硫氨酰-赖氨酰-BK是金黄色葡萄球菌致病和引发细菌性休克的一种新机制。因此,葡萄球菌蛋白酶特异性抑制剂和激肽受体拮抗剂可用于治疗这种疾病。